SPOTLIGHT: Researchers encounter stem cell success, setback


Amid the high hopes that stem cell therapies could revolutionize the treatment of a number of diseases, researchers at the University of Rochester and Cornell have made a discovery in animal trials that has serious implications, both good and bad, for the possibilities of stem cell research. Report

Suggested Articles

Although BridgeBio has grown from one program to 21 within five years, it will present four top prospects to investors during an R&D day on Tuesday.

Dewpoint Therapeutics aims to advance research in one of the more mysterious cell organelles: biomolecular condensates.

The FDA slapped a partial clinical hold on the phase 2/3 study of Inovio’s COVID-19 vaccine because it has “additional questions” about the trial.